person · Reporting owner

Kuechen Joerg

Disclosed activity across 1 company

Tapewire entity: 65058
SEC CIK: 0001938568

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
COGNEX CORPCGNX · Entity 3527	Head of Corporate M&A	February 20, 2026	February 24, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

COGNEX CORP

Report date February 20, 2026 · Filed February 24, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	6,032	Ending reported balance After 2026-02-21 transaction · row 11 11 source rows · reconciled sequence Row 1 · 2026-02-20 · Exercise / conversion · Acquired 11,029 · Balance 13,758 Row 2 · 2026-02-20 · Sale · Disposed 11,029 · Balance 2,729 Row 3 · 2026-02-20 · Exercise / conversion · Acquired 12,500 · Balance 15,229 Row 4 · 2026-02-20 · Sale · Disposed 12,500 · Balance 2,729 Row 5 · 2026-02-20 · Exercise / conversion · Acquired 35,642 · Balance 38,371 Row 6 · 2026-02-20 · Sale · Disposed 35,642 · Balance 2,729 Row 7 · 2026-02-20 · Sale · Disposed 2,729 · Balance 0 Row 8 · 2026-02-20 · Exercise / conversion · Acquired 5,325 · Balance 5,325 Row 9 · 2026-02-20 · Tax withholding · Disposed 2,575 · Balance 2,750 F1: This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 20, 2026 and are reported herein. Row 10 · 2026-02-21 · Exercise / conversion · Acquired 6,355 · Balance 9,105 Row 11 · 2026-02-21 · Tax withholding · Disposed 3,073 · Balance 6,032 F2: This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 21, 2026 and are reported herein.
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $33.04 · Expires 2035-02-18	Direct	44,112	Reported balance After 2026-02-20 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2026-02-20 · Exercise / conversion · Disposed 11,029 · Balance 44,112 F3: The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2025).
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $38.39 · Expires 2027-02-21	Direct	0	Reported balance After 2026-02-20 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2026-02-20 · Exercise / conversion · Disposed 12,500 · Balance 0 F4: The options vest in four equal annual installments on the first, second, third, and fourth anniversaries of the grant date (February 21, 2017).
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $39.44 · Expires 2034-02-20	Direct	53,461	Reported balance After 2026-02-20 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2026-02-20 · Exercise / conversion · Disposed 35,642 · Balance 53,461 F5: The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2024).
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.21 · Expires 2033-02-21	Direct	67,759	Reported balance Holding disclosure · report date 2026-02-20 · row 17 Instrument identity requires review; Table II rows are not merged. 1 source row Row 17 · Balance 67,759
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $47.95 · Expires 2032-08-04	Direct	39,894	Reported balance Holding disclosure · report date 2026-02-20 · row 18 Instrument identity requires review; Table II rows are not merged. 1 source row Row 18 · Balance 39,894
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $50.94 · Expires 2030-02-18	Direct	80,000	Reported balance Holding disclosure · report date 2026-02-20 · row 19 Instrument identity requires review; Table II rows are not merged. 1 source row Row 19 · Balance 80,000
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $51.49 · Expires 2029-02-19	Direct	45,000	Reported balance Holding disclosure · report date 2026-02-20 · row 20 Instrument identity requires review; Table II rows are not merged. 1 source row Row 20 · Balance 45,000
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $56.44 · Expires 2028-02-20	Direct	30,000	Reported balance Holding disclosure · report date 2026-02-20 · row 21 Instrument identity requires review; Table II rows are not merged. 1 source row Row 21 · Balance 30,000
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $64.43 · Expires 2032-02-22	Direct	49,530	Reported balance Holding disclosure · report date 2026-02-20 · row 22 Instrument identity requires review; Table II rows are not merged. 1 source row Row 22 · Balance 49,530
Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $90.50 · Expires 2031-02-16	Direct	29,486	Reported balance Holding disclosure · report date 2026-02-20 · row 23 Instrument identity requires review; Table II rows are not merged. 1 source row Row 23 · Balance 29,486
Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2026-02-21	Direct	0	Reported balance After 2026-02-21 transaction · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · 2026-02-21 · Exercise / conversion · Disposed 6,355 · Balance 0 F6: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F7: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively.
Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2027-02-20	Direct	8,874	Reported balance After 2026-02-20 transaction · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · 2026-02-20 · Exercise / conversion · Disposed 5,325 · Balance 8,874 F6: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F8: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 20, 2024), respectively.
Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2028-02-17	Direct	8,759	Reported balance Holding disclosure · report date 2026-02-20 · row 24 Instrument identity requires review; Table II rows are not merged. 1 source row Row 24 · Balance 8,759
Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2028-02-18	Direct	16,223	Reported balance Holding disclosure · report date 2026-02-20 · row 25 Instrument identity requires review; Table II rows are not merged. 1 source row Row 25 · Balance 16,223

Filing footnotes · ownership attribution and instrument terms

F1: This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 20, 2026 and are reported herein.

F2: This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 21, 2026 and are reported herein.

F3: The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 18, 2025).

F4: The options vest in four equal annual installments on the first, second, third, and fourth anniversaries of the grant date (February 21, 2017).

F5: The options vest in five approximately equal annual installments on the first, second, third, fourth, and fifth anniversaries of the grant date (February 20, 2024).

F6: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.

F7: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 21, 2023), respectively.

F8: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 20, 2024), respectively.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
February 16, 2023 Filed Feb 21, 2023 21:54 UTC	COGNEX CORP CGNX · Entity 3527	Exercise / conversionRestricted Stock Unit · Derivative	1,619	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001194210-23-000012 · edgardoc.xml · derivative · entry 3 Kuechen Joerg · CIK 0001938568 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,698 Underlying: Common Stock · 1,619 shares Expires 2024-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock. F3 · derivative.exercise_date: The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 16, 2021), respectively. Read SEC document
February 16, 2023 Filed Feb 21, 2023 21:54 UTC	COGNEX CORP CGNX · Entity 3527	Tax withholdingCommon Stock	561	$55.31	$31,028.91	Disclosure SEC source: 0001194210-23-000012 · edgardoc.xml · nonDerivative · entry 2 Kuechen Joerg · CIK 0001938568 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,763 F1 · kind: This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 16, 2023 and are reported herein. Read SEC document
February 16, 2023 Filed Feb 21, 2023 21:54 UTC	COGNEX CORP CGNX · Entity 3527	Exercise / conversionCommon Stock	1,619	$0.00	$0.00	Disclosure SEC source: 0001194210-23-000012 · edgardoc.xml · nonDerivative · entry 1 Kuechen Joerg · CIK 0001938568 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,324 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
August 04, 2022 Filed Aug 5, 2022 20:01 UTC	COGNEX CORP CGNX · Entity 3527	GrantNon-Qualified Stock Option (right to buy) · Derivative	39,894	$0.00 Strike: $47.95	$0.00	Disclosure SEC source: 0001938568-22-000004 · edgardoc.xml · derivative · entry 2 Kuechen Joerg · CIK 0001938568 · Chief Technology Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,894 Underlying: Common Stock · 39,894 shares Expires 2032-08-04 F1 · derivative.exercise_date: The options vest in two equal annual installments on the fourth and fifth anniversaries of the grant date (August 4, 2022). Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.